Real-world variability in dabigatran levels in patients with atrial fibrillation: comment

Search results

• Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.

  Author: Douxfils, J., 24 Oct 2015

  Supervisor: Dogne, J. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (External person) (Jury), Verhamme, P. B. (External person) (Jury), TEN CATE, H. (External person) (Jury) & Ageno, W. (External person) (Jury)

  Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences